[go: up one dir, main page]

IL91386A0 - Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it - Google Patents

Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it

Info

Publication number
IL91386A0
IL91386A0 IL91386A IL9138689A IL91386A0 IL 91386 A0 IL91386 A0 IL 91386A0 IL 91386 A IL91386 A IL 91386A IL 9138689 A IL9138689 A IL 9138689A IL 91386 A0 IL91386 A0 IL 91386A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
autoimmune diseases
treating autoimmune
paf antagonist
paf
Prior art date
Application number
IL91386A
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL91386A0 publication Critical patent/IL91386A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL91386A 1988-08-24 1989-08-22 Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it IL91386A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3828678 1988-08-24

Publications (1)

Publication Number Publication Date
IL91386A0 true IL91386A0 (en) 1990-04-29

Family

ID=6361480

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91386A IL91386A0 (en) 1988-08-24 1989-08-22 Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it

Country Status (11)

Country Link
EP (1) EP0361077A3 (en)
JP (1) JPH03500898A (en)
KR (1) KR900701276A (en)
AU (1) AU627763B2 (en)
DK (1) DK95890D0 (en)
HU (1) HUT59604A (en)
IL (1) IL91386A0 (en)
NZ (1) NZ230406A (en)
PH (1) PH26996A (en)
WO (1) WO1990001927A2 (en)
ZA (1) ZA896422B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69226877T2 (en) * 1991-05-31 1999-03-11 Genentech, Inc., South San Francisco, Calif. TREATMENT OF HIV-ASSOCIATED IMMUNE THROMBOPENIE PURPURA
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
JP3060287B2 (en) * 1995-10-09 2000-07-10 参天製薬株式会社 Aqueous eye drops containing apaphant as the main drug
WO1998043638A1 (en) * 1997-03-27 1998-10-08 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for autoimmune diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591596B1 (en) * 1985-12-13 1988-09-09 Roussel Uclaf NOVEL 4H-TRIAZOLO (4,3-A) (1,4) BENZODIAZEPINES, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
DE3778559D1 (en) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg THIENO-1,4-DIAZEPINE.
DE3610848A1 (en) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg NEW 1,4-DIAZEPINE
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines
DE3710921C2 (en) * 1986-10-21 1996-09-26 Korth Ruth Use of Gingkolide BN 52020, BN 52021 and BN 52063 for the treatment of arteriosclerosis
EP0268242B1 (en) * 1986-11-17 1992-03-18 Yoshitomi Pharmaceutical Industries, Ltd. Paf-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof

Also Published As

Publication number Publication date
HUT59604A (en) 1992-06-29
DK95890A (en) 1990-04-18
DK95890D0 (en) 1990-04-18
WO1990001927A3 (en) 1990-05-17
EP0361077A2 (en) 1990-04-04
HU896004D0 (en) 1990-11-28
KR900701276A (en) 1990-12-01
PH26996A (en) 1993-02-01
ZA896422B (en) 1991-04-24
AU627763B2 (en) 1992-09-03
JPH03500898A (en) 1991-02-28
EP0361077A3 (en) 1990-07-11
WO1990001927A2 (en) 1990-03-08
AU4017389A (en) 1990-03-01
NZ230406A (en) 1992-03-26

Similar Documents

Publication Publication Date Title
HUT54387A (en) Process for producing lhrh analogues and pharmaceutical compositions containing them
HUT74088A (en) Sustained-release pharmaceutical composition
GB9227166D0 (en) A method for preparing pharmaceutical compositions
HUT50851A (en) Process for producing intervenous pharmaceutical compositions
ZA887362B (en) Dosage form for treating cardiovascular diseases
HUT55414A (en) Process for producing reduced size lhrh analogues and pharmaceutical compositions containing tehm
HUT50445A (en) Process for producing pharmaceutical compositions suitable for preventing sexual diseases
HUT52394A (en) Process for producing ophthalmic pharmaceutical compositions comprising cyclosporin
EG18603A (en) A method for the preparation of pharmaceutical composition
EP0408496A3 (en) Solid dosage form for pharmaceutical substances
ZA901348B (en) Pharmaceutical compositions
HUT54695A (en) Process for producing new acetylcholinesteraze inhibitors and pharmaceutical compositions containing them
HUT54378A (en) Process for producing squalene-synthetaze inhibitors containing phosphours and pharmaceutical compositions containing them
HUP9901303A3 (en) A pharmaceutical composition for the treatment of autoimmune diseases
HUT48591A (en) Process for producing new fluoromethoxyphenyl-dihydro-pyridines and pharmaceutical compositions comprising these compounds
IL91386A0 (en) Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it
AU2690888A (en) Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
EP0409499A3 (en) Pharmaceutical compositions
GR900100364A (en) Method for preparating pharmaceutical compositions
GR880100333A (en) Method for preparating pharmaceutical compositions
IL90187A0 (en) Method for treating an auto-immune disease using succinyl-acetone and pharmaceutical compositions containing the same
HUT56269A (en) Pharmaceutical compositions
HUT48592A (en) Process for producing new fluoromethoxyphenyl-dihydropyridines and pharmaceutical compositions comprising these compounds
HU9203477D0 (en) Method for preparing water-dissoluble pharmaceutical preparaive
HUT59154A (en) Process for producing 6-methyl-19-norsteroids and pharmaceutical compositions comprising same